Literature DB >> 12172757

Do kidneys outgrow the risk of reflux nephropathy?

Malcolm G Coulthard1.   

Abstract

Three-quarters of human kidneys have segments that will allow intrarenal reflux if the person is one of the 1% that is also born with vesicoureteric reflux (VUR). It is likely that entry of infected urine into these segments produces permanent damage within just a few days, as it does in piglets and adult pigs. This very rapid course leaves no time for delay in diagnosing and treating urine infections in infants, the group that present the greatest clinical difficulties. It is proposed that the reason why the risk of scarring starts off high and falls to virtually nil by 4 years is not due to maturation that leads to an increased resistance to scarring, but because most vulnerable subjects have already scarred their kidneys in infancy. This proposed model has important implications for clinical management. First, it suggests that current practice identifies scars in children due to urine infection, but prevents few. Second, babies known to have VUR from birth, and protected from scarring with prophylactic antibiotics, will not outgrow their scarring risk by any particular age, but will remain at risk until they outgrow their reflux. This suggests their kidneys need to be protected from scarring until then, perhaps by antibiotic prophylaxis. Third, transplant recipients of any age with refluxing ureteric anastamoses or stents will carry a risk of developing a focal scar if they acquire a urine infection, and may need protection.

Entities:  

Mesh:

Year:  2002        PMID: 12172757     DOI: 10.1007/s00467-002-0877-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

Review 1.  May we go on with antibacterial prophylaxis for urinary tract infections?

Authors:  R Beetz
Journal:  Pediatr Nephrol       Date:  2005-10-21       Impact factor: 3.714

Review 2.  Febrile urinary tract infection, vesicoureteral reflux, and renal scarring: current controversies in approach to evaluation.

Authors:  Martin A Koyle; Jack S Elder; Steven J Skoog; Tej K Mattoo; Hans G Pohl; Pramod P Reddy; Jennifer M Abidari; Warren T Snodgrass
Journal:  Pediatr Surg Int       Date:  2011-02-09       Impact factor: 1.827

3.  Vesicoureteric reflux is not a benign condition.

Authors:  Malcolm G Coulthard
Journal:  Pediatr Nephrol       Date:  2008-06-27       Impact factor: 3.714

4.  A nurse led education and direct access service for the management of urinary tract infections in children: prospective controlled trial.

Authors:  Malcolm G Coulthard; Sue J Vernon; Heather J Lambert; John N S Matthews
Journal:  BMJ       Date:  2003-09-20

Review 5.  Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.

Authors:  Amelia E Barber; J Paul Norton; Travis J Wiles; Matthew A Mulvey
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-02       Impact factor: 11.056

6.  Radiographic evaluation of children with febrile urinary tract infection: bottom-up, top-down, or none of the above?

Authors:  Michaella M Prasad; Earl Y Cheng
Journal:  Adv Urol       Date:  2011-08-11

7.  Does prompt treatment of urinary tract infection in preschool children prevent renal scarring: mixed retrospective and prospective audits.

Authors:  Malcolm G Coulthard; Heather J Lambert; Susan J Vernon; Elizabeth W Hunter; Michael J Keir; John N S Matthews
Journal:  Arch Dis Child       Date:  2013-12-18       Impact factor: 3.791

Review 8.  Imaging studies and biomarkers to detect clinically meaningful vesicoureteral reflux.

Authors:  Michaella Maloney Prasad; Earl Y Cheng
Journal:  Investig Clin Urol       Date:  2017-05-24

9.  Imaging strategies for vesicoureteral reflux diagnosis.

Authors:  Constantinos J Stefanidis; Ekaterini Siomou
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

10.  The current evidence based medical management of vesicoureteral reflux: The Sickkids protocol.

Authors:  Sumit Dave; Antoine E Khoury
Journal:  Indian J Urol       Date:  2007-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.